Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Personalized Gene Therapy Treatment Market Set To Climb From $10.11 Billion In 2026 To $21.22 Billion By 2030
The personalized gene therapy treatment market size has expanded considerably in recent years. It is anticipated to increase from $8.38 billion in 2025 to $10.11 billion in 2026, reflecting a compound annual growth rate (CAGR) of 20.7%. This past growth is largely due to factors such as the increasing prevalence of genetic disorders, advancements in genomic sequencing technologies, early clinical success of targeted gene therapies, the expansion of specialized gene therapy research centers, and growing investment in precision medicine.
The personalized gene therapy treatment market size is set to experience substantial growth in the upcoming years, with projections indicating it will reach $21.23 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 20.4%. This expansion in the forecast period can be attributed to several factors including increasing regulatory approvals for personalized gene therapies, a rising demand for customized oncology treatments, the expansion of gene therapy manufacturing capabilities, the growing integration of AI in therapy design, and an increasing adoption of pharmacogenomics-guided treatments. Furthermore, major trends anticipated in the forecast period encompass the increasing adoption of gene editing-based therapies, a rising use of personalized treatment protocols, the growing integration of companion diagnostics, the expansion of viral and non-viral vector platforms, and an enhanced focus on precision oncology applications.
Get A Free Sample Report With In-Depth Market Insights:
Personalized Gene Therapy Treatment Market Growth Backed By Core Demand Fundamentals
The increasing incidence of genetic disorders is anticipated to stimulate the expansion of the personalized gene therapy treatment market in the future. Genetic disorders are conditions resulting from anomalies in DNA that disrupt normal bodily functions. The prevalence of these disorders is escalating due to rising parental age, as older reproductive cells carry a higher likelihood of mutations that can be transmitted to offspring. Personalized gene therapy addresses genetic disorders by precisely correcting the defective genes responsible for the condition, customizing treatment to an individual’s genetic makeup, thereby enhancing efficacy and reducing side effects. For instance, in October 2024, as per the Cystic Fibrosis Trust, a UK-based charity dedicated to supporting individuals with cystic fibrosis, approximately 11,148 cystic fibrosis (a genetic disorder) patients were registered in 2022, and this figure climbed to 11,318 in 2023, showing a 1.5% increase in patient registrations year over year. Consequently, the growing prevalence of genetic disorders is propelling the growth of the personalized gene therapy treatment market.
Personalized Gene Therapy Treatment Market Segment Landscape: Which Areas Lead Development?
The personalized gene therapy treatment market covered in this report is segmented –
1) By Therapy: Targeted Treatments, Pharmacogenomics
2) By Vector Type: Viral, Non-Viral
3) By Distribution Channel: Hospitals, Clinics, Home Administration, Other Distribution Channels
4) By Application: Oncology, Neurology, Hematological, Infectious Diseases, Ophthalmology, Other Applications
Subsegments:
1) By Targeted Treatments: Monoclonal Antibodies, Chimeric Antigen Receptor T-Cell Therapy (CAR-T), Small Interfering RNA (siRNA) Therapy, Antisense Oligonucleotides (ASO), Gene Editing Therapy
2) By Pharmacogenomics: Companion Diagnostics, Drug Metabolism Enzyme Testing, Genetic Biomarker Analysis, Single Nucleotide Polymorphism (SNP) Profiling, Adverse Drug Reaction (ADR) Prediction
Personalized Gene Therapy Treatment Market Growth Trends Reshaping The Competitive Landscape
Leading companies in the personalized gene therapy treatment market are increasingly focusing on forming strategic partnerships to boost their technological capabilities and make innovative therapies available to patients more efficiently. Strategic partnerships involve collaborative agreements between organizations, aiming to leverage each other’s strengths and resources for mutual development and a competitive advantage, while also sharing risks and benefits. For instance, in May 2025, Aldevron, a US-based company engaged in producing DNA, RNA, and protein, teamed up with Integrated DNA Technologies, a US-based provider of genomics solutions. Their collaboration aimed to create the world’s first mRNA-based personalized CRISPR therapy to treat an infant diagnosed with urea cycle disorder (UCD), a rare and life-threatening genetic condition. This N of 1 therapy was successfully developed and delivered in just six months, incorporating a custom guide RNA, an mRNA-encoded base editor, off-target safety services, and a clinically validated lipid nanoparticle delivery system. The development of this therapy signifies a major advancement in personalized in vivo base-editing treatments.
Personalized Gene Therapy Treatment Market Industry Leaders And Competitive Landscape
Major companies operating in the personalized gene therapy treatment market are Thermo Fisher Scientific Inc., Illumina Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, Guardant Health Inc., GeneDx LLC, Ancestry Inc., Oxford Nanopore Technologies plc, Genomic Health Inc., 23andMe Holding Co., Color Health Inc., Helix OpCo LLC, Personalis Inc., Dante Genomics, Gene By Gene Ltd., Veritas Genetics Inc., Futura Genetics, Nebula Genomics Inc., Pathway Genomics Corporation
View The Full Personalized Gene Therapy Treatment Market Report:
Personalized Gene Therapy Treatment Market Largest Region: Which Geography Holds The Biggest Share?
North America was the largest region in the personalized gene therapy treatment market in 2025. The regions covered in the personalized gene therapy treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
